PODD
Companies
NASDAQ
Insulet Corporation
Health Care
$301.59
+$40.51 (+15.52%)
Price Chart
Overview
About PODD
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
Market Cap
$13.4B
Volume
275.4M
Avg. Volume
277.7M
P/E Ratio
63.834625
Dividend Yield
0.00%
Employees
2.7K
Company Information
Risk & Correlation Analysis
Market Correlation
0.80
Moderate Correlation
Volatility
Medium (0.35)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PODD shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$13.4B
Volume275.4M
P/E Ratio63.83
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025